Comparison of fixed dose reduced-intensity conditioning with fludarabine and busulfan to PK-guided busulfan AUC (FluBu4K) in hematopoietic stem cell transplant for AML/MDS.

Autor: Rasor B; Department of Pharmacy, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Department of Pharmacy, Kettering Health Network, Kettering, OH, USA., Dickerson T; Department of Pharmacy, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Zhao Q; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Elder P; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Brammer JE; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Larkin K; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Jaglowski S; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Mims A; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Penza S; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Vasu S; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Wall SA; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., William B; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Saad A; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Roddy JVF; Department of Pharmacy, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Choe H; Division of Hematology, Department of Internal Medicine, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Puto M; Department of Pharmacy, James Cancer Hospital, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2021 Apr; Vol. 62 (4), pp. 944-951. Date of Electronic Publication: 2020 Nov 24.

Characteristics of hospitalizations among patients receiving immune checkpoint inhibitors at a community teaching hospital.

Autor: Rasor B; Department of Pharmacy, The James Comprehensive Cancer Center at The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Department of Pharmacy, Charles F. Kettering Medical Center, Kettering, OH, USA., Henderson R; Department of Pharmacy, Charles F. Kettering Medical Center, Kettering, OH, USA., Chan K; Department of Pharmacy, Charles F. Kettering Medical Center, Kettering, OH, USA.

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Jan; Vol. 26 (1), pp. 60-66. Date of Electronic Publication: 2019 Mar 29.

Enzyme‐Polymer‐Conjugate‐Based Pickering Emulsions for Cell‐Free Expression and Cascade Biotransformation.

Autor: Lu, Haofan¹ (AUTHOR), Ouyang, Jingping² (AUTHOR), Liu, Wan‐Qiu¹ (AUTHOR), Wu, Changzhu^2,3 (AUTHOR) wu@sdu.dk, Li, Jian¹ (AUTHOR) lijian@shanghaitech.edu.cn

Publikováno v: Angewandte Chemie. 12/21/2023, Vol. 135 Issue 52, p1-7. 7p.

Deletion of genes linked to the C1-fixing gene cluster affects growth, by-products, and proteome of Clostridium autoethanogenum.

Autor: Nwaokorie, Ugochi Jennifer, Reinmets, Kristina, de Lima, Lorena Azevedo, Pawar, Pratik Rajendra, Shaikh, Kurshedaktar Majibullah, Harris, Audrey, Köpke, Michael, Valgepea, Kaspar

Publikováno v: Frontiers in Bioengineering & Biotechnology; 2024, p1-13, 13p

Expanding the toolbox of probiotic Escherichia coli Nissle 1917 for synthetic biology.

Autor: Ba F; School of Physical Science and Technology, ShanghaiTech University, Shanghai, China., Zhang Y; School of Physical Science and Technology, ShanghaiTech University, Shanghai, China., Ji X; School of Physical Science and Technology, ShanghaiTech University, Shanghai, China., Liu WQ; School of Physical Science and Technology, ShanghaiTech University, Shanghai, China., Ling S; School of Physical Science and Technology, ShanghaiTech University, Shanghai, China., Li J; School of Physical Science and Technology, ShanghaiTech University, Shanghai, China.

Publikováno v: Biotechnology journal [Biotechnol J] 2024 Jan; Vol. 19 (1), pp. e2300327. Date of Electronic Publication: 2023 Oct 13.